Floatz logo

Trifluridine

Stage III Rectal Cancer AJCC v8

Academic and Community Cancer Research UnitedSmall moleculePhase 2Active
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
89/ 100

Competitive context

69 Active assets in the Stage III Rectal Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Irinotecan
Sun Yat-sen University
Phase 4BBB
FLUOROURACILUM
Seoul National University Hospital
Phase 3BBB
Eloxatin
Sun Yat-sen University
Phase 3BBB
Capecitabine
Tao Zhang
Phase 3BB
Irinotecan
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB

View all 50 →

Same molecule, other indications

Trifluridine is also rated in:

colorectal cancerDormant
BB
Indicative ·
67 / 100
View asset →
colorectal adenocarcinomaDormant
BB
Indicative ·
67 / 100
View asset →
Metastatic Colorectal CarcinomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →